Contemporary Clinical Trials Communications

Contemporary Clinical Trials Communications

当代临床试验通讯

  • 4区 中科院分区
  • Q4 JCR分区

期刊简介

《Contemporary Clinical Trials Communications》是由Elsevier出版社创办的英文国际期刊(ISSN: 2451-8654),该期刊长期致力于医学:研究与实验领域的创新研究,主要研究方向为Pharmacology, Toxicology and Pharmaceutics-Pharmacology。作为SCIE收录期刊(JCR分区 Q4,中科院 4区),本刊采用OA未开放获取模式(OA占比1%),以发表医学:研究与实验领域等方向的原创性研究为核心(研究类文章占比99.32%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在146篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Contemporary Clinical Trials Communications审稿周期约为20 Weeks。该刊近年未被列入国际预警名单,年发文量约146篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 146 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL ESCI Q4 146 / 191

23.8

学科:MEDICINE, RESEARCH & EXPERIMENTAL ESCI Q3 139 / 191

27.49

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL ESCI Q4 144 / 189

24.1

学科:MEDICINE, RESEARCH & EXPERIMENTAL ESCI Q4 146 / 189

23.02

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:2.6 SJR:0.625 SNIP:0.683
学科类别 分区 排名 百分位
大类:Medicine 小类:General Medicine Q2 225 / 669

66%

大类:Medicine 小类:Pharmacology Q3 228 / 328

30%

期刊发文

  • Activating the vagus nerve-adrenal anti-inflammatory axis to delay aging: A randomized controlled trial protoco

    Author: Sun, Chong; Fu, Meihong; Liu, Jiao; Zheng, Kebing; Chen, Shaoping; Deng, Lunsha; Zhuang, Yanping; Wang, Kai; Ren, Ruibao; Liang, Chao

    Journal: CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS. 2026; Vol. 51, Issue , pp. -. DOI: 10.1016/j.conctc.2026.101632

  • Effects of intermittent theta-burst stimulation (iTBS) on post-stroke depression (PSD): A study protocol for a single-center randomized controlled tria

    Author: Zhong, Yanbiao; Ren, Meng; Wang, Wenjing; He, Juanlian; Zhong, Yonghui; Xu, Jingjing; Li, YuanLi; Zhang, Sicong; Shan, Chunlei

    Journal: CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS. 2026; Vol. 49, Issue , pp. -. DOI: 10.1016/j.conctc.2026.101599

  • Efficacy and safety of SARS-CoV-2 neutralizing antibody, SCTA01, in high-risk outpatients diagnosed with COVID-19: A Phase II clinical tria

    Author: Diaz, Jorge; Fonseca, Allex; Yan, Lixin; Liu, Dongfang; Xie, Liangzhi

    Journal: CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS. 2025; Vol. 45, Issue , pp. -. DOI: 10.1016/j.conctc.2025.101496

  • SHengXIaN-QuYu DEcoction in the Treatment of Heart Failure with Reduced and Mildly-Reduced Ejection Fraction (SHINE-HF): rationale and design for a multicenter randomized controlled tria

    Author: Feng, Lina; Chen, Sizhen; Liu, Jiang; Li, Chunyan; Cao, Hongshuai; Tao, Liyuan; Fang, Fang; Huo, Feijiao; Liu, Lingling; Wubu'er, Palidan; Wang, Ming; Zhao, Xiaohua; Liu, Xiaojian; Xin, Hui; Li, Ding; Mao, Weisheng; Gui, Liang; Guan, Jianfei; Zhu, Zhiyang; Song, Haijun; Li, Shi; Song, Yingjing; Shi, Meiling; Zhang, Chao; Zhang, Zhiying; Li, Huiyun; Wang, Xiaobin; Yang, Baolong; Jin, Zhao; Du, Yifei; Gao, Yonghui; Cao, Lulei; Yang, Jiamei; Wang, Qiao; Kang, Naidan; Su, Lina; Zheng, Zhaoqi; Fan, Jiasai; Xu, Jiaying; Shi, Zaixiang; Ren, Jingyi; SHINE HF Investigator

    Journal: CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS. 2025; Vol. 45, Issue , pp. -. DOI: 10.1016/j.conctc.2025.101497

  • A three-arm randomized controlled trial protocol: Effects of telephone-based, layperson-delivered wisdom-enhancement narrative therapy and empathy-focused interventions on loneliness, social, and mental health in older adult

    Author: Tang, Vivien Foong Yee; Jiang, Da; Kahlon, Maninder; Chow, Esther Oi-wah; Yeung, Dannii Yuen-lan; Aubrey, Rhonda; Chou, Kee-Lee

    Journal: CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS. 2025; Vol. 45, Issue , pp. -. DOI: 10.1016/j.conctc.2025.101479